🇺🇸 FDA
Pipeline program

AVN944

090119

Unknown small_molecule terminated

Quick answer

AVN944 for Refractory Solid Tumors is a Unknown program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 1 ClinicalTrials.gov record(s).

Program details

Company
VERTEX PHARMACEUTICALS INC / MA
Indication
Refractory Solid Tumors
Phase
Unknown
Modality
small_molecule
Status
terminated

Clinical trials